Bank of Montreal’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Bank of Montreal’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Hold	0	–	–	–	3842
2021 Q1	–	Hold	0	–	–	–	5088
2020 Q4	–	Hold	0	–	–	–	4941
2020 Q3	–	Hold	0	–	–	–	4777
2020 Q2	–	Hold	0	–	–	–	4637
2020 Q1	–	Hold	0	–	–	–	4152
2019 Q4	–	Hold	0	–	–	–	4859
2019 Q3	–	Hold	0	–	–	–	4737
2019 Q2	–	Hold	0	–	–	–	4866
2019 Q1	–	Hold	0	–	–	–	4195
2015 Q4	–	Sell	-2	Closed	-$25K	–	4227
2015 Q3	$25K	Buy	+2	New	+$13.4K	﹤0.01%	3161

Other funds holding CANF

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

APA

American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Bank of Montreal's CANF Position: Q2 2021 in Review

Bank of Montreal held its Can-Fite BioPharma American Depositary Shares (CANF) position steady in Q2 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3842.

Bank of Montreal first reported a position in CANF in Q3 2015 and has held it in 1 quarter since. The position peaked at $25K in Q3 2015. 11 funds tracked by Wall St. Rank hold CANF as of Q2 2021.

Bank of Montreal held 0 shares of Can-Fite BioPharma American Depositary Shares worth $0 as of Q2 2021.
Bank of Montreal left its Can-Fite BioPharma American Depositary Shares share count unchanged in Q2 2021.
Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2021, its #3842 holding.
Bank of Montreal first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2015 and has held it in 1 quarter since.
Bank of Montreal's Can-Fite BioPharma American Depositary Shares position peaked at $25K in Q3 2015.
11 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.